You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物科技服務(08037.HK):華昇診斷中心已進行逾10萬次新型冠狀病毒檢測
阿思達克 08-18 09:53
中國生物科技服務(08037.HK)公布,集團與華大基因健康科技(香港)已經合資註冊成立華昇診斷中心,其主要業務為於香港提供醫學實驗室檢測服務。華昇診斷中心先前已經在香港設立一間新型冠狀病毒檢測實驗室,最近亦在香港額外設立及經營一間有16個氣膜的臨時實驗室,為香港市民提供新型冠狀病毒檢測,以識別隱形患者。額外的實驗室每日可進行大約10萬次單管測試,其將使華昇診斷中心之總檢測能力由每日3萬次增加至13萬次,使其成為香港擁有高檢測能力的新型冠狀病毒檢測實驗室之一。

目前,華昇診斷中心已經進行超過10萬次新型冠狀病毒檢測。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account